ZAMBIA ESSENTIAL

03
MEDICINE LIST
(ZEML)
2013
 Drug Presentation Level VEN

1 Drugs used in anaesthesia

1.1. Drugs used in general anaesthesia

1.1.1 Intravenous and intramuscular anaesthetics
1.1.1.1
Ketamin injection 10mg/ml (10 ml) II-IV V
1.1.1.2 Thiopentone sodium powder for reconstitution 1g and 5g vials II-IV V
1.1.2 Inhalation anaesthetics
1.1.2.1
Halothane inhalation II-IV V
1.1.2.2
Nitrous oxide medical gas II-IV E
1.1.3 Muscle relaxants
1.1.3.1 Suxamethonium chloride injection 50mg/ml, (2ml) II-IV V
1.1.4 Anticholinesterases
1.1.4.1
Neostigmine injection 2.5mg/ml, (1ml) II-IV V

1.2 Drugs used in local anaesthesia

1.2.1. Lignocaine injection 1% (10ml, 50ml) I-IV V
1.2.2 Lignocaine + adrenaline dental cartridge injection 2% (1 in 80,000) II-IV V

1.3 Drugs used in spinal anaesthesia

1.3.1
Bupivacaine/glucose injection 0.5%, (4ml) IV E

1
 Drug Presentation Level VEN

2. Drugs acting on the gastrointestinal system

2.1 Antacids
2.1.1 Aluminium hydroxide gel, chewable tablets I-IV E
2.12 Magnesium trisilicate Compound chewable tablets, mixture I-IV E

2.2. Antispasmodics
2.2.1 Hyoscine butyl bromide injection 20mg/ml, (1ml) II-IV E
2.2.2
Propantheline bromide tablets 15mg I-IV E

2.3 Ulcer healing drugs

2.3.1
Cimetidine tablets 200mg II-IV E
2.3.2
Omeprazole tablets 10mg, II-IV E
2.3.3
Ranitidine tablets 150mg II-IV E
2.3.4 Tripotassium dicitratobismuthate tablets 120mg II-IV E
2.3.5
Clarithromycin tablets 250mg II-IV E

2.4. Antidiarrhoeals
2.4.1
Codeine phosphate tablets15mg II-IV E
2.4.2
Loperamide tablets 2mg IV E
2.4.3
Nitazoxanide suspension 100mg III-IV E

2
 Drug Presentation Level VEN

2.5. Laxatives
2.5.1
Glycerol suppository 1g,4g I-IV E
2.5.2
Senna tablets 7.5mg II-IV E

2.6 Drugs used for treating haemorrhoids

2.6.1 Bismuth subgallate and zinc oxide suppository, cream II-IV E

3 Drugs acting on the central nervous system

3.1 Anxiolytics and Antipsychotic drugs

3.1.1
Alprazolum tablets 0.25 microgram III-IV E
3.1.2
Lorazepam tablets 2mg tablets III-IV E
3.1.3 Diazepam tablets 2mg, injection 5mg/ml (2ml) II-IV V
3.1.4
Medazolam injection 1mg/ml III E
3.1.5 Selective serotonin reuptake inhibitors
3.1.5.1
Sertraline tablets 50mg IV E

3.2 Tricyclic Antidressants

3.2.1 Clomipramine tablets 25mg III E

3.3 Anti-depressant drugs

3.3.2
Fluoxetine tablets 20mg IV E

3
 Drug Presentation Level VEN

3.3.4
Lithium carbonate tablets 300mg IV E
3.3.5
Sodium valproate tablets 200mg, II-IV E

3.4 Antiepileptic drugs

3.4.1
Carbamazepine tablets 200mg II-IV V
injection 5mg/ml I-IV V
3.4.2
Lamotrigine tablets 25mg, 50mg I-IV V
3.4.3
Ethosuximide capsules 250mg III-IV V
3.4.4 Phenobarbitone tablets 30mg, injection 200mg/ml II-IV V
3.4.5
Phenytoin tablets 100mg II-IV V
3.4.6 Sodium valproate tablets 200mg, syrup 200mg/5ml II-IV V
3.4.7
Clonazepam tablets 0.5mg, 2mg II-IV V
3.4.8
Acetazolamide tablets 250mg IV E
3.4.9
Gabapentin tablets 600mg IV E

3.5 Drugs used in Parkinsonism and related disorders

3.5.1
Benzhexol tablets 5mg II-IV V
3.5.2
Bromocriptine tablets 2.5mg III-IV E
3.5.3 Procyclidine tablets 5mg, injection 5mg/ml,(2ml) I-IV E
3.5.4
Selegiline tablets 5mg, 10mg III-IV E
3.5.5 Levodopa tablets 125mg, 250mg, 500g III-IV E

4
 Drug Presentation Level VEN

3.6 Drugs used in nausea

3.6.1 Cyclizine tablets 50mg, injection 50mg/ml IV E
3.6.2
Domperidone tablets 10mg II-IV E
3.6.3 Metoclopramide tablets 10mg, injection 5mg/ml (2ml) II-IV E
3.6.4
Prochlorperazine tablets 5mg III-IV E
3.6.5 Promethazine tablet 25mg, injection 25mg/ml(2ml) I-IV V
3.6.6 Trifluoperazine tablets 1mg, injection 1mg/ml II-IV E

3.7 Analgesics
3.7.1 Non-opiod analgesics
3.7.1.1 Acetyl salicylic acid (aspirin) tablets 300mg I-IV V
3.7.1.2 Paracetamol (acetaminophen) tablets 100mg, 500mg, mixture 120mg/5ml I-IV V
3.7.2 Opioid analgesics
3.7.2.1
Dihydrocodeine tablets 30mg II-IV E
3.7.2.2 Morphine sulphate tablets 10mg, injection 10mg/ml II-IV V
3.7.2.3 Pethidine tablets 50mg, injection 50mg/ml II-IV V

3.8 Anti-migraine drugs

3.8.1
Ergotamine tartrate tablets 1mg II-IV E

3.9 Stimulants
3.9.1
Methylphenidate tablets 5mg IV E

5
 Drug Presentation Level VEN

3.10 Non-steroidal anti-inflammatory drugs

3.10.1.
Ibuprofen tablets 200mg, 400mg I-IV E

4 Drugs used in the treatment of infections

4.1 Antibacterial drugs

4.1.1 Penicillins
4.1.1.1 Benzathine penicillin injection 2.4 MU vial I-IV E
4.1.1.2
Benzyl penicillin injection 5MU vial I-IV V
4.1.1.3 Phenoxymethyl penicillin tablets 250mg, suspension 125mg/5ml I-IV E
4.1.1.4
Procaine penicillin injection 3MU vial I-IV E
4.1.2 Broad-spectrum penicillins
4.1.2.1 Amoxycillin tablets/capsules 250mg, syrup 125mg/5ml I-IV V
4.1.2.2
Ampicillin injection 500mg vial II-IV V
4.1.3 Penicillinase-resistant penicillins
4.1.3.1 Amoxycillin+clavulanic acid tablets 375mg(250mg+125mg) III-IV E
4.1.3.2
Cloxacillin capsules 250mg injection 500mg II-IV V
4.1.3.3
Flucloxacillin capsules 250mg injection 250mg III-IV E
4.1.4 Aminoglycosides
4.1.4.1
Gentamicin injection 40mg/ml, (2ml) I-IV V
4.1.4.2
Kanamycin injection 1g vial I-IV E

6
 Drug Presentation Level VEN

4.1.5 Aminocyclitol
4.1.5.1
Spectinomycin injection 2g vial III-IV E
4.1.6 Sulphonamides and trimethoprim
4.1.6.1 Co-trimoxazole tablets 120mg, 480mg, (sulfamethoxazole + I-IV V
trimethoprim)mixture 240mg/5ml
4.1.6.2
Trimethoprim tablets 200mg I-IV E
4.1.7 quinolones
4.1.7.1 Ciprofloxacin tablets 250mg III-IV E
I.V 2mg/ml 50ml,100ml bottle IV E
4.1.7.2 Nalidixic acid tablets 500mg, suspension 30mg/5ml I-IV V
4.1.7.3 Ofloxacin tablets 400mg, I.V 2mg/ml IV E
4.1.8 Nitro-furan drugs
4.1.8.1
Nitrofurantoin tablets 50mg I-IV E
4.1.9 Macrolides
4.1.9.1 Erythromycin tablets 250mg, injection 500mg vial, I-IV V
syrup 125mg/5ml
4.1.9.2 Azithromycin capsules/tablets 250mg, Suspension 200mg/5ml II-IV V
4.1.9.10
Clindamycin capsule 75mg, suspension III-IV E
75mg/5ml, injection 150mg/ml
4.1.10 Cephalosporins and cephamycins
4.1.11.1
Cefotaxime injection 500mg vial III-IV E
4.1.11.2
Cefoxitine injection 1g, 2g vial II-IV E

7
 Drug Presentation Level VEN

4.1.11.3
Ceftriaxone injection 250mg,500mg,1g vial II-IV E
4.1.11.4 Cephalexin tablets or capsules 250mg III-IV E
4.1.12 Tetracyclines
4.1.12.1
Doxycycline tablets 100mg I-IV E
4.1.12.2
Tetracycline tablets 250mg I-IV E
4.1.13
Metronidazole tablets 200mg I-IV V
IV infusion 5mg/ml, (100ml) III-IV V

Other antibacterials

4.1.14
Chloramphenicol capsules 250mg, suspension II-IV V
125mg/5ml, injection 1g vial
4.2 Anti-tuberculosis drugs
4.2.1 Rifampicin + Isoniazid Tablets 150 mg + 75 mg I-IV V
4.2.2 Rifampicin + Isoniazid Tablets 60 mg + 30 mg I-IV V
4.2.3 Rifampicin + Isoniazid + Ethambutol Tablets 150 mg + 75 mg + 275 mg I-IV V
4.2.4 Rifampicin + Isoniazid + Pyrazinamide Tablets 60 mg + 30 mg + 150 mg I-IV V
4.2.5 Rifampicin + Isoniazid + Ethambutol + Pyrazinamide Tablets 150 mg + 75 mg + 275 mg+ 400mg I-IV V
4.2.6
Ethambutol Tablets 400 mg I-IV V
4.2.7
Pyrazinamide Tablets 400 mg I-IV V
4.2.8 Streptomycin Injection 1 g, 5 g vial I-IV V

8
 Drug Presentation Level VEN

4.3 Anti-leprosy drugs

4.3.1
Clofazimine capsules 50mg,100mg II-IV V
4.3.2
Dapsone tablets 10mg,25mg,50mg II-IV V
4.3.3 Rifampicin capsules 150mg, 300mg, syrup 100mg/5ml II-IV V

4.4 Antifungal drugs (also see section 12.3 and 13.3)

4.4.1
Amphotericin B injection 50mg III-IV E
4.4.2 Clotrimazole vaginal tablet 500mg II-IV E
4.4.3 Fluconazole 50mg, 150mg, 299mg, IV 2mg/ml III-IV V
4.4.4
Flucytosine Injection 10mg/ml III-IV E
4.4.5
Griseofulvin tablets 125mg III-IV E
4.4.6
Ketoconazole tablets 200mg II-IV E
4.4.7
Nystatin vaginal tablets 100,000 IU II-IV V

4.5 Anti-protozoal drugs

4.5.1 Antimalarials
4.5.1.1.
Artemether-lumefantrine tablets 20mg/120mg I-IV V
4.5.1.2 Pyrimethamine + sulphadoxine tablets 25mg/500mg I-IV V
4.5.1.3 Quinine tablets 300mg, injection 300mg/1ml (2ml) I-IV V
4.5.2 Amoebocides
4.5.2.1
Metronidazole tablets 200mg I-IV V
4.5.2.2
Tinidazole tablets 500mg III-IV E

9
 Drug Presentation Level VEN

4.6 Trypanocides
4.6.1 Melarsoprol injection 3.6% III-IV V
4.6.2
Suramin sodium injection 1g vial III-IV V

4.7 Drugs used in pneumocystis pneumonia

4.7.1 Co-trimoxazole (sulfamethoxazole + trimethoprim) tablets 120mg, 480mg, mixture 240mg/5ml II-IV V

4.8 Herpes zoster and varicella zoster drugs

4.8.1
Acyclovir cream II-IV E
4.8.2
Acyclovir tablets 200mg, 400mg II-IV E

4.9 Antiretrovirals
4.9.1 Nucleoside Reverse Transcriptase Inhibitors
4.9.1.1
Abacavir tablets 300mg II-IV E
4.9.1.3
Lamivudine, 3TC tablets 150mg II-IV E
4.9.1.4 Lamivudine + zidovudine tablets 150/250mg II-IV E
4.9.1.5 Lamivudine + Stavudine tablets 150/30mg II-IV E
4.9.1.6 Lamivudine + Stavudine + Nevirapine tablets 150/30/200mg II-IV E
4.9.1.7
Stavudine, D4T tablets 30mg II-IV E
4.9.1.8 Zidovudine, ZDV, AZT tablets 100mg, 250mg II-IV E
4.9.1.9
Tenofovir tablets 245mg II-IV E
4.9.1.10
Emitricitabine tablets 200mg II-IV E

10
 Drug Presentation Level VEN

4.9.1.11
Tenofovir/Emitricitabine tablets 300/200mg II-IV E
4.9.2 Non-nucleoside Reverse Transcriptase inhibitors
4.9.2.1
Efavirenz tablets 600mg II-IV E
4.9.2.2
Nevirapine tablets 200mg II-IV E
4.9.3 Protease inhibitors
4.9.3.2
Ritonavir tablets 600mg II-IV E
4.9.3.3
Lopinavir/Ritonavir tablets 133.3/33.3mg II-IV E
4.9.3.4 Nelfinavir tablets 750mg II-IV E

4.10 Anthelmintics
4.10.1
Mebendazole chewable tablets 100mg I-IV V
4.10.2
Niclosamide tablets 500mg I-IV E
4.10.3 Pyrantel tablets 125mg, suspension 250mg/5ml I-IV E
4.10.4
Thiabendazole tablets 500mg II-IV E
4.10.5
Albendazole tablets 400mg II-IV E

4.11 Schistosomicides
4.11.1
Praziquantel tablets 600mg I-IV V

4.12 Anti-filarials
4.12.1
Diethylcarbamazine tablets 50mg III-IV E
4.12.2
Ivermectin tablets III-IV E

11
 Drug Presentation Level VEN

4.12.3
Suramin sodium injection 1g vial III-IV V

5. Drugs acting on the endocrine system and obstetrics, gynaecology and contraception

5.1 Drugs used in diabetes

5.1.1 Insulin
5.1.1.1 Short acting (soluble) injection 100 IU/ml 10ml II-IV V
5.1.1.2 Isophane Insulin, Biphasic Insulin Injection 100IU/ml 10ml II-IV V
5.1.1.3 Actraphane or mixtard (30/70)Intermediate-and long acting Injection 100IU/ml 10ml II-IV V
5.1.2 Oral hypoglycaemics
5.1.2.1
Chlorpropamide tablets 100,250mg II-IV V
5.1.2.2
Glibenclamide tablets 5mg II-IV V
5.1.2.3
Metformin tablets 500mg II-IV V
Other Antidiabetics
5.1.4.1
Glucagon Injection II-IV V

5.2 Preparations acting on the thyroid

5.2.1
Carbimazole tablets 5mg III-IV E
5.2.2
Iodine aqueous solution III-IV E
5.2.3
Thyroxin tablets 100mcg III-IV V

5.3 Corticosteroids

12
 Drug Presentation Level VEN

5.3.1 Dexamethasone tablets 500mcg, injection 5mg/ml (5ml) III-IV V

5.3.2 Hydrocortisone sodium succinate injection 100mg vial I-IV V
5.3.3
Prednisolone tablets 5mg I-IV V

5.4 Oestrogens and progestogens

5.4.1
Norethisterone tablets 5mg III-IV E
5.4.2 Conjugated oestrogens tablets 625micrograms III-IV E

5.5 Androgens and anti androgens

5.5.1
Cyproterone tablets 50mg III-IV E
5.5.2
Stilboestrol tablets 1mg III-IV E
5.5.3 Testosterone capsules 40mg, injection oily depot 250mg/ml,(1ml) III-IV E

5.6 Other endocrine drugs

5.6.1
Bromocriptine tablets 2.5mg III-IV E
5.6.2
Clomiphene citrate tablets 50mg III-IV E
5.6.3
Danazol capsules 100mg III-IV E

5.7 Drugs used in obstetrics and gynaecology

5.7.1 Drugs acting on smooth muscle
5.7.1.1 Anticonvulsants
5.7.1.1.1
Magnesium sulphate injection 50% II-IV E

13
 Drug Presentation Level VEN

5.7.1.2 Prostaglandins and oxytocics

5.7.1.2.1 Dinoprostone tablets 500mcg, injection 1mg/ml III-IV E
5.7.1.2.2 Ergometrine maleate tablets 250mcg,500mcg, injection 200mcg/ml I-IV V
5.7.1.2.3
Ergometrine/ oxytocin injection II-IV E
5.7.1.2.4
Oxytocin injection 10IU/ml,1ml II-IV V
5.7.1.2.5
Misoprostol Tablet 200microgram I-IV V
5.7.1.3 Myometrial relaxants
5.7.1.3.1
Salbutamol injection 500mcg/ml (1ml) II-IV V

5.8 Contraceptives
5.8.1 Combined oral contraceptives
5.8.1.1 Ethinyloestradiol/levonorgestrel tablet 30mg/150mcg I-IV V
5.8.2 Emergency contraception
5.8.2.1
Levonorgestrel tablet 750mcg I-IV V
5.8.3 Progesterone-only oral contraceptives
5.8.3.1
Levonorgestrel tablet 30mcg I-IV V
5.8.4 Progesterone-only injectable contraceptives
5.8.4.1 Medroxyprogesterone acetate injection 150mg/ml,1ml I-IV V
5.8.4.2 Norethisterone enanthate injection, oily 200mg/ml,1ml I-IV V
5.8.5 Barrier methods
5.8.5.1 Female condoms artificial plastic sheath I-IV V
5.8.5.2 Intrauterine device (IUD) copper long coil type (Copper T 380A) II-IV V

14
 Drug Presentation Level VEN

5.8.5.3 Male condoms latex sheath with/without spermicide I-IV V

5.8.5.4
Menefegol vaginal foaming tablets I-IV E
5.8.6 Implants
5.8.6.1 Levonorgestrel implant 38mg in silicone capsule IV V

6 Drugs used in the treatment of diseases of the respiratory system and allergy

6.1 Bronchodilators
6.1.1
Adrenaline 1 in 1000, (1ml) I-IV V
6.1.2 Aminophylline tablets 100mg, injection 25mg/ml (10ml) I-IV V
suppositories 50mg,360mg I-IV E
6.1.3 Salbutamol tablets 2mg, syrup 2mg/5ml, I-IV V
inhaler 100mcg/dose I-IV E

6.2 Corticosteroids
6.2.1 Hydrocortisone sodium succinate injection 100mg vial I-IV V
6.2.2
Prednisolone tablets 5mg II-IV V

6.3 Asthma prophylaxis therapy

6.3.1
Beclomethasone inhaler 50mcg/dose II-IV E
6.3.2 Sodium chromoglicate inhaler 5mg/dose II-IV E
6.4 Antihistamines

15
 Drug Presentation Level VEN

6.4.1
Chlorpheniramine tablets 4mg I-IV E
6.4.2
Promethazine tablets 10mg, 25mg I-IV E

6.5 Oxygen
6.5.1
Oxygen medical gas I-IV V

7 Drugs used in the treatment of diseases of the cardiovascular system

7.1 Cardiac glycosides

7.1.1 Digoxin tablets 250mcg,injection 250mcg/ml, (2ml), elixir II-IV V
7.2 Diuretics
7.2.1 Thiazides
7.2.1.2 Bendrofluazide tablets 5mg II-IV E
7.2.1.3
Hydrochlorthiazide tablets 50mg II-IV E
7.2.2 Loop diuretics
7.2.2.1 Frusemide tablets 40mg, injection 10mg/ml, (2ml) II-IV V

7.2.3 Potassium sparing diuretics

7.2.3.1 Amiloride + hydrochlorthiazide tablets 5mg/50mg II-IV E
7.2.4 Osmotic diuretics
7.2.4.1
Mannitol injection 20% 250ml bottle II-IV V

16
 Drug Presentation Level VEN

7.3 Antiarrhythmic drugs

7.3.1
Amiodarone tablets 100mg III-IV E
7.3.2
Atenolol tablets 50mg II-IV E
7.3.3 Digoxin tablets 250mcg, injection 250mcg/ml,(2ml) II-IV V
7.3.4 Lignocaine injection 1%, (10ml, 25ml) II-IV V
7.3.5
Quinidine tablets 200mg, 300mg IV V

7.4 Anti-angina drugs

7.4.1
Atenolol tablets 50mg III-IV E
7.4.2 Glyceryl trinitrate sub-lingual tablets 500mcg II-IV E
7.4.3
Isosorbide mononitrate tablets 10mg II-IV E
7.4.4 Nifedipine tablets or capsules 10mg Antihypertensive drugs II-IV E

7.5 Diuretics
7.5.1 Thiazide diuretics
7.5.1.1
Hydrochlorthiazide tablets 50mg II-IV E
7.5.1.2 Potassium sparing diuretics
7.5.1.2.1 Amiloride + hydrochlorthiazide tablets 5mg/50mg II-IV E
7.5.1.2.2
Spironolactone tablets 25mg II-IV E
7.5.2 Beta blockers
7.5.2.1
Atenolol tablets 50mg II-IV E
7.5.2.2
Propranolol tablets 10mg, 40mg II-IV E

17
 Drug Presentation Level VEN

7.5.2.3
Carvedilol tablets 3.125mg IV E
7.5.2.4
Labetalol tablets 100mg III-IV E
7.5.2.5
Metoprolol tablets 50mg, 100mg III-IV E
7.5.3 Vasodilators
7.5.3.1 Hydralazine tablets 25mg, injection 20mg ampoule II-IV E
7.5.4 ACE inhibitors
7.5.4.1
Captopril tablets25mg III-IV E
7.5.4.2
Lisinopril tablets 5mg, 10mg, 25mg III-IV E
7.5.4.3
Enalapril tablets 5mg, 10mg, 20mg III-IV E
ACE inhibitors II
7.5.4.4
Losartan tablets 25mg, 50mg IV E
7.5.5 Calcium channel blockers
7.5.5.1 Nifedipine tablets or capsules10mg, 20mg III-IV E
7.5.5.2
Verapamil tablets 40mg III-IV E
7.5.5.3
Amlodipine tablets 5mg, 10mg III-IV E

7.6 Drugs used in shock - sympathomimetics

7.6.1 Adrenaline injection 1 in 1000 (1mg/ml) I-IV V

7.7 Alpha-adrenoceptor blocking agents

7.7.1
Prazosin tablets 500 mcg, 1mg III-IV E
7.8 Lipid-regulating drugs

18
 Drug Presentation Level VEN

7.8.1 Statins
7.8.1.1
Simvastatin tablets 20mg, 40mg IV E

7.9. Inotropic sympathomimetics

7.9.1
Dopamine injection 40mg/ml IV E

8 Drugs used in the treatment of malignant disease: anti-neoplastic drugs

8.1 Actinomycin D injection 500mcg III-IV V

8.2 Asparaginase injection 1000 IU
8.3 Azathioprine tablets 50mg, injection 50mg vial IV V
8.4 Bleomycin injection 15 unit ampoule IV V
8.5 Busulphan tablets 500mcg IV V
8.6 Calcium folinate tablets 15mg IV V
8.7 Carboplatin injection 10mg/ml
8.8 Carmustine vial 100mg IV V
8.9 Chlorambucil tablets 2mg IV V
8.11 Cisplatin injection 1mg/ml IV V
8.12 Cyclophosphamide tablets 50mg, injection 100mg IV V
8.13 Cytarabine injection 100mg,500mg,1g vial IV V
8.14 Cytosine arabinosate injection100mg IV V
8.15 Cyproteron acetate tablets 50mg, 100mg IV V

19
 Drug Presentation Level VEN

8.16 Darcabazine injection 200mg IV V

8.17 Daunorubicin injection 20mg IV V
8.18 Doxorubicin injection 10mg,50mg IV V
8.19 Etoposide IV infusion 20mg/ml IV V
8.20 Fludarabine my mouth 40mg/m2, injection, infusion IV V
8.21 Filgastrin injection 300mcg/ml IV V
8.22 Fluorouracil injection 25mg/ml IV V
8.23 Hydroxyurea capsules 500mg IV V
8.24 Ifosfamide injection, 1g, 2g vial IV V
2.29 Imatinib tablets 100mg IV V
8.25 Interferon injection 300mg IV V
8.26 Lomustine capsules 40mg IV V
8.27 Melphalan tablets 2mg, injection 100mg IV V
8.28 Mercaptopurine tablets 50mg IV V
8.29 Methotrexate tablets 2.5mg, injection 50mg IV V
8.30 Mitomycin injection 40mg IV V
8.31 Mustine injection 10mg IV V
2.32 Paclitaxel IV infusion 6mg/ml IV V
8.33 Procarbazine capsules 50mg IV V
8.34 Stilboeastrol tablets 1mg IV V
8.35 Tamoxifen tablets 20mg IV V
8.36 Temozolmide capsules 5mg IV V

20
 Drug Presentation Level VEN

8.37 Thioguanine tablets 40mg IV V

8.38 Vinblastine injection 1mg/ml
8.39 Vincristine injection 1mg, 5mg III-IV V

9 Drugs acting on the eye

9.1 Ophthalmic diagnosis

9.1.1
Fluorescein sodium eye drops, strips III-IV E

9.2 Anti-infective preparations

9.2.1 Antibacterial
9.2.1.1 Chloramphenicol eye drops 0.5% eye ointment 1% II-IV E
9.2.1.2
Chloramphenicol/dexamethasone eye drops 15/0.1% III-IV E
9.2.1.3 Framycetin eye drops, eye ointment III-IV E
9.2.1.4
Tetracycline eye ointment 1% I-IV E
9.2.1.5 Oxy-tetracycline/Hydrocortisone eye drops 3%/1% III-IV E
9.2.1.6
Neomycin/betamethasone eye drops 0.5%/o.1% III-IV E
9.2.1.7
Gentamicin eye drops 0.3% II-IV E
9.2.1.8 Cefotaxime injection 500mg, Ig vial III-IV E
9.2.2 Antifungals – Preparations are not generally available
and could be made extemporaneously
9.2.2.1
Pivodine Iodine eye drops 2% III-IV E

21
 Drug Presentation Level VEN

9.2.2.2
Natamycin eye suspension 5% IV E
9.2.2.3
Econazole eye suspension 1% IV E
9.2.2.4
Miconazole eye suspension 10mgg/ml IV E
9.2.2.5 Amphoteracine B eye solution 0.05% -0.2% IV E
9.2.3 Antiviral
9.2.3.1
Aciclovir eye ointment III-IV E
9.2.3.2 Ganciclovir IV infusion 500mg vial IV E
9.2.3.3
Forscarnet IV infusion 24mg/ml IV E

9.3 Anti-inflammatory preparations

9.3.1 Betamethasone eye drops, eye ointment III-IV E
9.3.2 Hydrocortisone acetate eye drops, eye ointment II-IV E
9.3.3
Dexamethasone eye drops 0.1% III-IV E
9.3.4 Prednisolone eye drops 0.5%, 1% III-IV E
9.3.5
Tropicamide eye drop 1% III-IV E
9.3.6 Sodium chromoglycate eye drops 2% III-IV E

9.4 Miotics and anti-glaucoma drugs

9.4.1
Pilocarpine eye drops 2%, 4% III-IV E

9.5 Mydriatic drugs

9.5.1
Atropine sulphate eye drops 1% III-IV E

22
 Drug Presentation Level VEN

9.6 Systemic preparations

9.6.1
Acetazolamide sodium tablets 250mg III-IV V

9.7 Local anaesthetics

9.7.1 Lignocaine hydrochloride eye drops 4% III-IV E

9.8 Postaglandin Analogue

9.8.1
Latanoprost eye drops 50mcg/ml IV E

9.9 Sympathomimetics
9.9.1
Dipivefrine eye drops 0.1% IV E

9.10 Beta-blocker
9.10.1 Timolol maleate eye drops 0.25% or 0.5% III-IV E

9.11 Diuretics
9.11.1
Cyclopenthiazide tablets 0.5mg IV E

9.12 Artificial tears

9.12.1
Hypromellose eye drops 0.3mg III-IV E

23
 Drug Presentation Level VEN

9.13 Hyperosmatic agents

9.13.1
Mannitol solution in water 20% III-IV E
9.13.2 Urea solution 30% in 10% invert sugar III-IV E

10 Blood

10.1 Anti-coagulants
10.1.1
Heparin injection 5000IU/ml,1ml II-IV V
10.1.2
Warfarin tablets 1mg,5mg
II-IV V

10.2 Anti-haemorrhagic
10.2.1 Amino caproic acid Effervescent powder 3g III-IV E
Oral suspension 10mg/5ml
10.2.2 Fibrinogen dry or freeze dried powder III-IV V
10.2.3 Human anti-haemophiliac fraction(dried) 3 units/ml IV E
10.2.4 Phytomenadione (vitamin K) injection 10mg/ml,(1ml) II-IV V

10.3 Haemopoetics
10.3.1
Ferrous sulphate tablets 50mg,200mg I-IV V
10.3.2
Folic acid tablets 5mg I-IV V
10.3.3 Hydroxocobalamin (vitamin B12) injection 1mg/ml,1ml II-IV E
10.3.4 Iron dextran injection 50mg iron in 2ml ampoule II-IV E

24
 Drug Presentation Level VEN

11 Nutrition

11.1 Vitamins, minerals and dietary supplements

11.1.1 Ascorbic acid (vitamin C) tablets 50mg,200mg I-IV E
11.1.2 Calcium gluconate injection 10%, (5ml,10ml) III-IV E
11.1.3 Ergocalciferol (vitamin D) tablets 50,000 IU, solution 3000 IU/ml II-IV E
11.1.4
Nicotinamide tablets 50mg II-IV E
11.1.5
Pyridoxine (vitamin B6) tablets 50mg I-IV E
11.1.6 Retinol (vitamin A) capsules/tablets 200,000IU I-IV E
11.1.7 Riboflavine (vitamin B2) tablets 5mg III-IV E
11.1.8 Thiamine (vitamin B1) tablets 50mg III-IV E

11.2 Electrolyte and water replacement

11.2.1 Oral administration
11.2.1.1 Oral rehydration salts sachet 27.9g powder to make 1 litre I-IV V
11.2.1.2 Potassium chloride tablets slow-release 600mg II-IV E
11.2.2 Infusions
11.2.2.1 Dextrose (glucose) solution 5%, 20, 50% I-IV V
11.2.2.2
Potassium chloride solution 11.2% II-IV E
11.2.2.3
Sodium bicarbonate solution 4.2% III-IV V
11.2.2.4 Sodium chloride (normal saline) solution 0.9% I-IV V
11.2.2.5 Sodium lactate and glucose (Darrows) solution, full and half strength I-IV V

25
 Drug Presentation Level VEN

11.2.2.6 Sodium lactate compound (Ringers lactate) solution I-IV V

11.2.2.7 Water for injection 2ml, 5ml, 10 ml I-IV V
11.2.3 Plasma substitutes
11.2.3.1
Dextran 40 solution 10% III-IV V
11.2.3.2
Gelatin (as polygeline) solution III-IV E

12 Drugs acting on the skin

12.1 Topical corticosteroids

12.1.1
Betamethasone cream/ointment 0.1% III-IV E
12.1.2
Hydrocortisone cream/ointment 1% I-IV E

12.2 Soothing preparations

12.2.1
Aqueous lotion I-IV E
12.2.2
Calamine lotion I-IV E
12.2.3
Zinc oxide cream I-IV E

12.3 Antifungal preparations

12.3.1
Miconazole nitrate cream 2% III-IV E
12.3.2
Ketokonazole tablets 200mg III-IV E
12.3.3
Griseofulvin tablets 500mg II-IV E

26
 Drug Presentation Level VEN

12.4 Anti-bacterial preparations

12.4.1
Tetracycline ointment I-IV E

12.5 Antiseptic preparations

12.5.1
Gentian violet solution I-IV E
12.5.2
Potassium permanganate solution I-IV E

12.6 Anti-parasitic preparations

12.6.1
Benzyl benzoate application 25% I-IV E
12.6.2
Malathion lotion 0.5% I-IV E
12.6.3
Permethrin cream 1% I-IV E

12.7 Keratoplastics and keratolytics

12.7.1
Coal tar solution 5% I-IV E
12.7.2
Dithranol ointment 1% III-IV E
12.7.3 Podophylline paint 15% in compound benzoin tincture II-IV E
12.7.4 Salicylic acid ointment 5%, 10%, 20% I-IV E

12.8 Acne preparations

12.8.1
Salicylic acid lotion I-IV E
12.8.2
Benzyl peroxide lotion I-IV E

27
 Drug Presentation Level VEN

12.9 Surgical disinfectants

12.9.1
Cetrimide solution 1% I-IV E
12.9.2 Chlorhexidine + cetrimide concentrated solution (1.5%/15%) I-IV E
12.9.3 Chlorhexidine gluconate concentrated solution 5% I-IV V
12.9.4
Chloroxylenol concentrated solution 4.8% I-IV E
12.9.5
Povidone iodine solution 10% I-IV V
12.9.6 Sodium hypochlorite 0.1% available chlorine I-IV V

12.10.
Antivirus 12.10.1 Acyclovir cream 5% II-IV E
Tablets 50mg II-IV E

13 Drugs used in the treatment of diseases of the ear, nose and throat

13.1 Drugs acting on the ear

13.1.1
Betamethasone eye/ear drops III-IV E
13.1.2
Gentamicin + hydrocortisone ear drops II-IV E
13.1.3
Sodium bicarbonate ear drops III-IV E
13.1.4
Vegetable oil ear drops I-IV E

13.2 Drugs acting on the nose: topical nasal decongestants

13.2.1
Normal saline nasal drops II-IV E

28
 Drug Presentation Level VEN

13.3 Drugs acting on the throat

13.3.1
Chlorhexidine mouth wash 0.2% I-IV E
13.3.2 Ketaconazole tablets 200mg, suspension 100mg/5ml I-IV E
13.3.3
Miconazole oral gel I-IV E
13.3.4
Nystatin oral suspension I-IV E

14 Drugs used in the treatment of musco-skeletal disorder

14.1 Drugs used in rheumatic diseases

14.1.1 Acetyl salicylic acid tablets 300mg I-IV V
14.1.2
Ibuprofen tablets 200mg I-IV E

14.2 Drugs used in gout

14.2.1
Allopurinol tablets 100mg III-IV E
14.2.2.
Colchicine tablets 500mcg IV E

15 Immunological products

15.1 Antisera, immunoglobulins and anti-toxins

15.1.1
Anti-D immunglobulin injection II-IV V
15.1.2
Diphtheria antitoxin injection II-IV V
15.1.3.
Mamba anti-sera injection II-IV V

29
 Drug Presentation Level VEN

15.1.4
Polyvalent snake anti-sera injection II-IV V
15.1.5
Tetanus antitoxin injection I-IV V

15.2 Vaccines
15.2.1
BCG injection I-IV V
15.2.3
Diptheria-pertussis injection I-IV V
tetanus, heamophilia influenza B
and heapatitis B (Pentavalent,) I-IV V
15.2.4
Hepatitis B injection II-IV E
15.2.5
Measles injection I-IV V
15.2.6
Poliomyelitis injection I-IV V
15.2.7
Rabies injection I-IV V
15.2.8
Tetanus toxoid (TT) injection I-IV V
15.2.9
Typhoid injection III-IV E
15.2.10
Yellow fever injection III-IV E

16 Antidotes and other substances used in poisoning

16.1 General treatment of poisoning

16.1.1
Activated charcoal powder I-IV V
16.1.2 Ipecacuanha syrup 0.14% ipecacuanha alkaloids I-IV V

30
 Drug Presentation Level VEN

16.2 Specific treatment of poisoning

16.2.1
Atropine injection 1mg/ml, (1ml) III-IV V
16.2.2
Naloxone injection 400mcg/1ml III-IV V
16.2.3 Pralidoxine mesylate injection 200mg/ml, (5ml) III-IV V
16..2.3.
N-acetylcysteine 20% solution IV E

31
 Drug Presentation Level VEN